NON-SMALL CELL LUNG CANCER STAGE IV
Clinical trials for NON-SMALL CELL LUNG CANCER STAGE IV explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CANCER STAGE IV trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCER STAGE IV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New biosimilar aims to match keytruda for lung cancer
Disease control OngoingThis study tests whether SB27, a biosimilar drug, works as well as the standard treatment Keytruda for people with advanced non-squamous non-small cell lung cancer. About 555 adults who have not had prior treatment for their stage IV cancer will receive either SB27 or Keytruda al…
Matched conditions: NON-SMALL CELL LUNG CANCER STAGE IV
Phase: PHASE3 • Sponsor: Samsung Bioepis Co., Ltd. • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
Spinal injection combo shows promise for Tough-to-Treat brain metastases
Disease control OngoingThis early-phase study tests whether giving two immunotherapy drugs (nivolumab and ipilimumab) directly into the spinal fluid, along with the same drugs through an IV, is safe and effective for people with lung cancer or melanoma that has spread to the lining of the brain. The tr…
Matched conditions: NON-SMALL CELL LUNG CANCER STAGE IV
Phase: PHASE1 • Sponsor: University of Zurich • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC